NEW YORK, November 9, 2021 / PRNewswire / – According to Insight Partners’ study on “Medical Collagen Market to 2028 – Global Analysis and Forecast – By Source, Product, Application, and Geography,” the medical collagen market is expected to reach $ 957.4 million by 2028 onwards $ 629.2 million in 2021; it is expected to grow at a CAGR of 6.2% during 2021-2028. The growth of the market is attributed to the increase in collagen applications in the medical industry and the increase in FDA approvals and product launches.
Get exclusive sample pages from the medical collagen market at https://www.theinsightpartners.com/sample/TIPRE00012952/
In 2020, North America dominated the global medical collagen market. Market growth in the region is attributed to demand for medical collagen in reconstructive surgeries, tissue engineering, bone grafts, and wound and burn treatments, among others. In addition, frequent product launches increase market growth. In April 2019, Collagen Matrix, Inc., has received FDA approval for its innovative line of mineral collagen composite bioactive moldable bone graft matrix. OssiMend Bioactive Moldable Bone Graft Matrix is a fine combination of organic carbonate apatite bone mineral, bioactive 45S5 glass and highly purified type I collagen that can be molded into mastic to fill irregular defect sites. The new matrix joined the company’s broad line of implantable collagen and mineral-based medical devices. However, the COVID-19 pandemic is straining the region’s public health systems, disrupting and delaying many types of critical health care. A recent survey by the World Health Organization found that health services are among the most frequently disrupted. 7 out of 10 countries in the world are experiencing disruptions with the United States, Canada, and Mexico. In addition, low-income countries face additional challenges due to the scarcity of health care infrastructure. Restrictive measures have been proposed in South Korea, Malaysia, Singapore, The Philippines, and India to prevent disease transmission. All of these factors will impact the medical collagen market for a short time.
According to the source, the medical collagen market is segmented into cattle, pigs and others. The cattle segment held the largest market share in 2020, and furthermore, it is expected to register the market’s highest CAGR during the forecast period. Based on the product, the medical collagen market is segmented into gelatin, hydrolyzed collagen, native collagen, and others. Gelatin segment held 35.69% market share in 2020. On the basis of application, the medical collagen market is segmented into hemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, grafts bone, diagnostics and more. The wound care segment held the largest market share in 2020; however, the bone grafting segment is expected to register a significant CAGR during 2021-2028.
Download the latest COVID-19 Analysis on Medical Collagen Market Growth Research Report at https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00012952/
Growing FDA Approvals and Product Launches Fuel Growth in Medical Collagen Market
Various players operating in the medical collagen market are developing and launching new products to expand their geographic reach and ability to cater to many customers. For example, in April 2019, Collagen Matrix, Inc., a leading regenerative medicine company, manufacturer of collagen and mineral-based medical devices, has received 510 (k) approval from the FDA for its innovative line of graft matrix bioactive moldable bone made from OssiMend mineral collagen composite.
Additionally, in 2018, Wright Medical Group NV received FDA approval for its AUGMENT Injectable Bone Grafting. It consists of a recombinant human growth factor derived from platelets and a mixture of type I collagen and beta tricalcium phosphate. Likewise, in 2016, the United States Food and Drug Administration (FDA) approved Avedro’s Corneal Collagen Crosslinking (CXL) to treat keratoconus and other types of corneal ectasia. Continuous product advancements and approvals of medical collagen products further drive the growth of medical collagen market.
Medical Collagen Market: Segment Overview
In terms of application, the bone grafts segment is expected to register the highest CAGR in the medical collagen market during the forecast period. The factors driving the growth of the segment are the increasing prevalence of bone and joint disorders, the increasing demand for dental bone grafts, and the organic and inorganic growth strategies of the market players. In 2018, Collagen Matrix, Inc., a global manufacturer of collagen and mineral-based medical devices, launched OssiMend bone graft matrices in Asia.
Medical collagen market: competitive landscape and key developments
DSM, Integra Lifesciences Corporation; Collagen Matrix, Inc .; Glue, Collagen Solutions Plc; Innocoll; Symatesis; Gelita AG; Collplant Biotechnologies Ltd; and Croda Interntional PLC are among the key companies operating in the medical collagen market. The main players are focused on launching new products, expanding and diversifying their market presence and acquiring new customers, thereby exploiting existing business opportunities.
Order copy of Medical Collagen Market Share, Strategy and Forecast 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00012952/
In October 2020, Innocoll launched the XARACOLL (bupivacaine HCI) implant, indicated for the relief of post-surgical pain. XARACOLL is a unique, non-injectable drug-device combination available as a fully bioabsorbable collagen implant containing bupivacaine hydrochloride.
In july 2020, Collagen Solutions Plc and NovaBone have entered into a new collaboration agreement with a minimum term of three years for the supply of specialized collagen biomaterials specific to their line of bone graft products used in orthopedic and dental applications.
In April 2019, the Spine business unit of Collagen Matrix, Inc. has received FDA approval for its innovative line of bioactive moldable collagen mineral composite bone graft matrix.
In October 2017, Integra LifeSciences launched Revize and Revize-X Collagen Matrix for plastic and reconstructive surgery. Revize and Revize-X are derived from the fetal bovine dermis, rich in type III collagen. Revize-X is a stretchable matrix that provides up to twice the initial coverage area when hydrated and fully expanded. It features a mesh pattern that allows for vascular growth and increased conformability.
Browse related reports and get a sample copy
Native collagen market Forecasts until 2028 – COVID-19 impact and global analysis by source (bovine, porcine, poultry, marine, others); Application (Food and Beverages, Health, Cosmetics, Others) and Geography – https://www.theinsightpartners.com/sample/TIPRE00010435/
Vegan Collagen Market Forecast until 2028 – COVID-19 impact and global analysis by type (serum, capsule and others); Application (beauty, wound healing, inflammation reduction and others) and geography – https://www.theinsightpartners.com/sample/TIPRE00019340/
Collagen Sponge Market Forecast until 2028 – COVID-19 impact and global analysis by type (small size, medium size, large size); Application (hospital, dental clinic, others) – https://www.theinsightpartners.com/sample/TIPRE00012949/
Collagen Supplements Market Forecasts until 2028 – COVID-19 impact and global analysis by source (animal, plant); Type (powders, capsules and gums, drinks and shots, others); Distribution channel (hypermarkets and supermarkets, specialty stores, online retailers, others) and geography – https://www.theinsightpartners.com/sample/TIPRE00019658/
The Insight Partners is a one-stop-shop for industrial research in actionable intelligence. We help our clients find solutions to their research needs through our syndicated research and advisory services. We specialize in industries such as Semiconductors & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Health Informatics, Manufacturing & Construction, Medical Devices , technology, media and telecommunications, chemicals and materials.
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: + 1-646-491-9876
Press release: https://www.theinsightpartners.com/pr/medical-collagen-market
More research: https://www.openpr.com/news/archive/139407/The-Insight-Partners.html
SOURCE Insight partners